Knowledge and Acceptability of Fecal Microbiota Transplantation Among Patients, Caregivers, and Health Care Providers in Ethiopia - Top-Institutions - MDSpire

Knowledge and Acceptability of Fecal Microbiota Transplantation Among Patients, Caregivers, and Health Care Providers in Ethiopia

  • By

  • Brandie Banner Shackelford

  • Kiya Kedir

  • Ahmed Babiker

  • Bizunesh Sintayehu

  • Abel Abera Negash

  • Alemseged Abdissa

  • Workeabeba Abebe Taye

  • Eyob Beyene

  • Michael H Woodworth

  • Monique M Hennink

  • November 4, 2025

  • 0 min

Share

Top Institutions in Infectious Disease

Brief introduction explaining scope and methodology.

  • #1

    Massachusetts General Hospital
    Massachusetts General Hospital

    Boston, MA

    Key Differentiators

    • Infectious Diseases
    • Gastroenterology
    • Microbiome Research

  • #2

    Johns Hopkins University
    Johns Hopkins University

    Baltimore, MD

    Key Differentiators

    • Infectious Diseases
    • Microbiome Science
    • Global Health

  • #3

    University of California, San Diego
    University of California, San Diego

    San Diego, CA

    Key Differentiators

    • Microbiome Research
    • Infectious Diseases
    • Gastroenterology

  • #4

    London School of Hygiene & Tropical Medicine
    London School of Hygiene & Tropical Medicine

    London, N/A

    Key Differentiators

    • Global Health
    • Infectious Diseases
    • Implementation Science

  • #5

    Addis Ababa University
    Addis Ababa University

    Addis Ababa, N/A

    Key Differentiators

    • Infectious Diseases
    • Global Health
    • Nutrition

Original Source(s)

Knowledge and Acceptability of Fecal Microbiota Transplantation Among Patients, Caregivers, and Health Care Providers in Ethiopia

  • by Brandie Banner Shackelford, Kiya Kedir, Ahmed Babiker, Bizunesh Sintayehu, Abel Abera Negash, Alemseged Abdissa, Workeabeba Abebe Taye, Eyob Beyene, Michael H Woodworth, Monique M Hennink

  • November 4, 2025

Related Content

Ankylosing spondylitis and the gut microbiome: future research hotspots and trends

Refining Vancomycin Use in Early CDI

A modified dosing approach could reshape recurrence prevention strategies.

Multiniche mycobiome profiling identifies distinctive fungal dysbiosis in common variable immunodeficiency